ChEMBL ID: CHEMBL2109151
Mechanism of action: Immunoglobulin epsilon Fc receptor antagonist
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to LUMILIXIMAB